Cite

HARVARD Citation

    Luan, J. et al. (2020). SLFN11 is a general target for enhancing the sensitivity of cancer to chemotherapy (DNA-damaging agents). Journal of drug targeting. pp. 33-40. [Online]. 
  
Back to record